Literature DB >> 1955749

The role of transforming growth factor-beta in inflammatory processes.

S M Wahl1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1955749     DOI： 10.1007/bf02919701

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  35 in total

1.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta.

Authors:  J B Allen; H L Wong; P M Guyre; G L Simon; S M Wahl
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

4.  Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.

Authors:  T Espevik; I S Figari; G E Ranges; M A Palladino
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

5.  Cell adhesion protein receptors as targets for transforming growth factor-beta action.

Authors:  R A Ignotz; J Massagué
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

6.  Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils.

Authors:  G R Grotendorst; G Smale; D Pencev
Journal:  J Cell Physiol       Date:  1989-08       Impact factor: 6.384

7.  Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

Authors:  J H Kehrl; A B Roberts; L M Wakefield; S Jakowlew; M B Sporn; A S Fauci
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

8.  Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.

Authors:  S M Wahl; D A Hunt; H L Wong; S Dougherty; N McCartney-Francis; L M Wahl; L Ellingsworth; J A Schmidt; G Hall; A B Roberts
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

9.  Distribution and modulation of the cellular receptor for transforming growth factor-beta.

Authors:  L M Wakefield; D M Smith; T Masui; C C Harris; M B Sporn
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

10.  Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.

Authors:  J B Allen; C L Manthey; A R Hand; K Ohura; L Ellingsworth; S M Wahl
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307
View more
  4 in total

1.  Regulation of complement C3 synthesis by interleukin-1 and transforming growth factor-beta in rat non-transformed intestinal epithelial cell line, IEC-6.

Authors:  A Andoh; Y Fujiyama; K Hata; K Sumiyoshi; T Bamba
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

2.  Expression of TGF-beta in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-gamma, but enhancement of IL-10, in carrageenin-induced oedema in mice.

Authors:  A Ianaro; D Xu; C A O'Donnell; M Di Rosa; F Y Liew
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

Review 3.  Transforming growth factor beta and the cell surface in tumor progression.

Authors:  M J Newman
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

4.  Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium.

Authors:  K Dickson; A Philip; H Warshawsky; M O'Connor-McCourt; J J Bergeron
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.